Clinical Trial Update: InORS - International Observational Registry on Schizophrenia With Injectable Risperidone and Oral Antipsychotics

View source ↗

Summary

An observational registry of schizophrenia treatment using injectable risperidone and oral antipsychotics that has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Risperdal Consta (risperidone long-acting injectable)
• Risperidone (oral) (risperidone)

Snippet

Sponsor: Janssen-Cilag International NV | Conditions: Schizophrenia | Status: COMPLETED